Role of FDG-PET and PET/CT in the diagnosis and management of vasculitis

European Journal of Radiology

Volumn 73, Issue 3, 2010, Pages 504-509

  Zerizer, Imene ^a   Tan, Kathryn ^a   Khan, Sameer ^a   Barwick, Tara ^a   Marzola, Maria Cristina ^b   Rubello, Domenico ^b   Al Nahhas, Adil ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b 'Santa Maria della Misericordia' Hospital   (Italy)

Author keywords

Diagnosis; FDG; PET; PET CT; Response to treatment; Vasculitis

Indexed keywords

DIFFERENTIAL DIAGNOSIS; FALSE POSITIVE; FDG; FDG PET; GIANT CELLS; SENSITIVITY VALUES;

IMAGING TECHNIQUES;

DIAGNOSIS;

FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; STEROID;

COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC VALUE; FOLLOW UP; GIANT CELL ARTERITIS; HUMAN; IMAGE ANALYSIS; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; REVIEW; SCINTIANGIOGRAPHY; SENSITIVITY AND SPECIFICITY; VASCULITIS;

DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; HUMANS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; VASCULITIS;

EID: 77949654358     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2010.01.021     Document Type: Review

References (43)

1. Jennette J.C., Falk R.J., Andrassy K., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37 February(2) (1994) 187-192
2. Fries J.F., Hunder G.G., Bloch D.A., et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum 33 August(8) (1990) 1135-1136
3. 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med 48 January(1) (2007) 35-45
4. 18F-FDG PET. Nucl Med Commun 27 July(7) (2006) 547-549
5. Reuter H., Wraight E.P., Qasim F.J., and Lockwood C.M. Management of systemic vasculitis: contribution of scintigraphic imaging to evaluation of disease activity and classification. Q J Med 88 July(7) (1995) 509-516
6. Genereau T., Lortholary O., Guillevin L., et al. Temporal 67gallium uptake is increased in temporal arteritis. Rheumatology (Oxford) 38 August(8) (1999) 709-713
7. Chen C.C., Kerr G.S., Carter C.S., et al. Lack of sensitivity of indium-111 mixed leukocyte scans for active disease in Takayasu's arteritis. J Rheumatol 22 March(3) (1995) 478-481
8. Yamada S., Kubota K., Kubota R., Ido T., and Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 36 July(7) (1995) 1301-1306
9. 18F-FDG uptake in experimental soft-tissue abscesses in rats. Radiology 223 May(2) (2002) 446-451
10. Babior B.M. The respiratory burst of phagocytes. J Clin Invest 73 March(3) (1984) 599-601
11. Salvarani C., Cantini F., and Hunder G.G. Polymyalgia rheumatica and giant-cell arteritis. Lancet 372 July(9634) (2008) 234-245
12. Schmidt W.A., Seifert A., Gromnica-Ihle E., Krause A., and Natusch A. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology (Oxford) 47 January(1) (2008) 96-101
13. Blockmans D., Maes A., Stroobants S., et al. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford) 38 May(5) (1999) 444-447
14. Bleeker-Rovers C.P., Bredie S.J., van der Meer J.W., Corstens F.H., and Oyen W.J. Fluorine 18 fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis. Am J Med 116 January(1) (2004) 50-53
15. 18F-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology (Oxford) 43 February(2) (2004) 241-242
16. 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 55 February(1) (2006) 131-137
17. 18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 32 June(6) (2005) 674-681
18. 18F)fluoro-deoxyglucose positron emission tomography in the assessment of large vessel vasculitis. Clin Exp Rheumatol 21 November(6 Suppl 32) (2003) S15-S22
19. Meller J., Strutz F., Siefker U., et al. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging 30 May(5) (2003) 730-736
20. Tato F., and Hoffmann U. Clinical presentation and vascular imaging in giant cell arteritis of the femoropopliteal and tibioperoneal arteries. Analysis of four cases. J Vasc Surg 44 July(1) (2006) 176-182
21. Vanderschueren S., Knockaert D., Adriaenssens T., et al. From prolonged febrile illness to fever of unknown origin: the challenge continues. Arch Intern Med 163 May(9) (2003) 1033-1041
22. Bleeker-Rovers C.P., Bredie S.J., van der Meer J.W., Corstens F.H., and Oyen W.J. F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Neth J Med 61 October(10) (2003) 323-329
23. Jaruskova M., and Belohlavek O. Role of FDG-PET and PET/CT in the diagnosis of prolonged febrile states. Eur J Nucl Med Mol Imaging 33 August(8) (2006) 913-918
24. Watts R., Al-Taiar A., Mooney J., Scott D., and Macgregor A. The epidemiology of Takayasu arteritis in the UK. Rheumatology (Oxford) 48 August(8) (2009) 1008-1011
25. Ben-Haim S., Gacinovic S., and Israel O. Cardiovascular infection and inflammation. Semin Nucl Med 39 March(2) (2009) 103-114
26. 18F-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging 31 May(5) (2004) 627-634
27. Arend W.P., Michel B.A., Bloch D.A., et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33 August(8) (1990) 1129-1134
28. Kerr G. Takayasu's arteritis. Curr Opin Rheumatol 6 January(1) (1994) 32-38
29. Lagneau P., Michel J.B., and Vuong P.N. Surgical treatment of Takayasu's disease. Ann Surg 205 February(2) (1987) 157-166
30. Hara M., Goodman P.C., and Leder R.A. FDG-PET finding in early-phase Takayasu arteritis. J Comput Assist Tomogr 23 January(1) (1999) 16-18
31. Andrews J., Al-Nahhas A., Pennell D.J., et al. Non-invasive imaging in the diagnosis and management of Takayasu's arteritis. Ann Rheum Dis 63 August(8) (2004) 995-1000
32. 18F-FDG PET coregistered with enhanced CT. J Nucl Med 46 June(6) (2005) 917-922
33. Mueller M HJPCea. Diagnosis of vasculitis with F-18 FDG-PET/CT: quantification of arterial wall activity in vasculitis patients and controls. J Nucl Med 48(Suppl 2):224. 1-1-2007 [Ref Type: Abstract].
34. Bural G.G., Torigian D.A., Chamroonrat W., et al. FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging 35 March(3) (2008) 562-569
35. 18F-FDG PET/CT. J Nucl Med 45 November(11) (2004) 1816-1821
36. 18F]fluorodeoxyglucose in human monocyte-macrophages in vitro. Eur J Nucl Med Mol Imaging 30 February(2) (2003) 267-273
37. Belhocine T., Blockmans D., Hustinx R., Vandevivere J., and Mortelmans L. Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data. Eur J Nucl Med Mol Imaging 30 September(9) (2003) 1305-1313
38. Blockmans D., Bley T., and Schmidt W. Imaging for large-vessel vasculitis. Curr Opin Rheumatol 21 January(1) (2009) 19-28
39. Merkel P. Update on a prospective study of MR and PET in Takayasu's. In: Abstract at the fourth international conference on giant cell arteritis and polymyalgia rheumatica; 2008.
40. 18F-FDG-PET imaging for pulmonary lesions. Nucl Med Commun 30 June(6) (2009) 455-461
41. 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 42 September(9) (2001) 1412-1417
42. Blockmans D., Stroobants S., Maes A., and Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 108 February(3) (2000) 246-249
43. Beggs A.D., and Hain S.F. F-18 FDG-positron emission tomographic scanning and Wegener's granulomatosis. Clin Nucl Med 27 October(10) (2002) 705-706